Brief: Orphazyme Announces Update On Regulatory Review Of Arimoclomol In The European Union

Strategic Partners A/S

23/02/2022 21:08

Feb 23 (Reuters) - Orphazyme A/S  ORPHA.CO :
    * ANNOUNCES UPDATE ON REGULATORY REVIEW OF ARIMOCLOMOL IN
THE
EUROPEAN UNION
    * TODAY BEEN NOTIFIED BY CHMP OF A NEGATIVE TREND VOTE ON
MAA FOR
ARIMOCLOMOL IN NPC FOLLOWING AN ORAL EXPLANATION
    * CONSIDERS IT UNLIKELY THAT THIS POSITION WILL CHANGE
BEFORE
FORMAL VOTE IS UNDERTAKEN NEXT MONTH
    * TREND VOTE INDICATES THAT CHMP'S CURRENT ORIENTATION IS TO
NOT
APPROVE ARIMOCLOMOL WHEN IT CONVENES BY END OF MARCH 2022
    * WILL NOW ASSESS COMPANY'S STRATEGIC OPTIONS AND PROVIDE AN
UPDATE TO MARKET AT APPLICABLE TIME

Source text for Eikon:  ID:nGNE4nTFpf 
Further company coverage:  ORPHA.CO 

 ((Reuters.Briefs@thomsonreuters.com;))